Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2019

Open Access 01-12-2019 | Research article

Illness management and recovery: one-year follow-up of a randomized controlled trial in Danish community mental health centers: long-term effects on clinical and personal recovery

Authors: Sofie Bratberg Jensen, Helle Stentoft Dalum, Lisa Korsbek, Carsten Hjorthøj, John Hagel Mikkelsen, Karin Thomsen, Kristen Kistrup, Mette Olander, Jane Lindschou, Kim T. Mueser, Merete Nordentoft, Lene Falgaard Eplov

Published in: BMC Psychiatry | Issue 1/2019

Login to get access

Abstract

Background: Illness Management and Recovery (IMR) is a curriculum-based rehabilitation program for people with severe mental illness with the short-term aim of improving illness self-management and the long-term aim of helping people achieve clinical and personal recovery.

Method

Participants with schizophrenia or bipolar disorders were recruited from three community mental health centers in the Capital Region of Denmark and randomized to receive group-based IMR and treatment as usual or only the usual intervention. All outcomes were assessed at baseline, postintervention, and the one-year follow-up. Long-term outcomes were categorized according to clinical recovery (i.e., symptoms, global functioning, and hospitalization) and personal recovery (i.e., hope and personal agency). Generalized linear mixed model regression analyses were used in the intent-to-treat analysis.

Results

A total of 198 participants were included. No significant differences were found between the IMR and control groups in the Global Assessment of Functioning one year after the intervention, nor were there significant differences in symptoms, number of hospital admissions, emergency room visits, or outpatient treatment.

Conclusion

The present IMR trial showed no significant effect on clinical and personal recovery at the one-year follow-up. Together with the results of other IMR studies, the present study indicates that the effect of IMR on symptom severity is unclear, which raises questions regarding the impact of IMR on functioning. Additionally, IMR did not affect personal recovery. Although more research is needed, the results indicate that the development of other interventions should be considered to help people with severe mental illness achieve a better level of functioning and personal recovery.

Trial registration

Literature
1.
Mueser KT, et al. The illness management and recovery program: rationale, development, and preliminary findings. Schizophr Bull. 2006;32(Suppl 1):S32–43.PubMedPubMedCentralCrossRef
2.
Anthony W. Recovery from mental illness: the guiding vision of the mental health service system in the 1990s. Psychiatr Rehabil J. 1993;16(4):11–23.
3.
4.
Mueser KT, et al. Psychosocial treatments for schizophrenia. Annu Rev Clin Psychol. 2013;9:465–97.PubMedCrossRef
5.
Andreasen NC, et al. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005;162(3):441–9.PubMedCrossRef
6.
Gingerich S. M.K.T., IMR Illness Management and Recovery Personalized Skills and Strategies for Those with Mental illness Implementation Guide. THIRD ed. Dartmouth PRC: Hazelden; 2011.
7.
8.
Levitt AJ, et al. Randomized controlled trial of illness management and recovery in multiple-unit supportive housing. Psychiatr Serv. 2009;60(12):1629–36.PubMedCrossRef
9.
Fardig R, et al. A randomized controlled trial of the illness management and recovery program for persons with schizophrenia. Psychiatr Serv. 2011;62(6):606–12.PubMedCrossRef
10.
Salyers MP, et al. Integrating assertive community treatment and illness management and recovery for consumers with severe mental illness. Community Ment Health J. 2010;46(4):319–29.PubMedCrossRef
11.
Salyers MP, et al. A randomized controlled trial of illness management and recovery with an active control group. Psychiatr Serv. 2014;65(8):1005–11.PubMedCrossRef
12.
Tan CHS, et al. Illness management and recovery program for mental health problems: reducing symptoms and increasing social functioning. J Clin Nurs. 2017;26(21–22):3471–85.PubMedCrossRef
13.
Hasson-Ohayon I, Roe D, Kravetz S. A randomized controlled trial of the effectiveness of the illness management and recovery program. Psychiatr Serv. 2007;58(11):1461–6.PubMedCrossRef
14.
Gingerich SMK. Illness Management and Recovery. Rockwill, Md: Substance Abuse and Mental Health Services Administration, Center for Mental Health Services; 2003.
15.
Ishak RB, et al. The effect of illness self-management and recovery program in reducing symptoms and increasing social functioning of the people with mental illness in the community: a preliminary study. Ann Acad Med Singap. 2012;1:S11.
16.
17.
Dalum HS, et al. Illness management and recovery: clinical outcomes of a randomized clinical trial in community mental health centers. PLoS One. 2018;13(4):e0194027.PubMedPubMedCentralCrossRef
18.
Surtees PG, Kendell RE. The hierarchy model of psychiatric symptomatology: an investigation based on present state examination ratings. Br J Psychiatry. 1979;135:438–43.PubMedCrossRef
19.
Pedersen G, Hagtvet KA, Karterud S. Generalizability studies of the global assessment of functioning-Split version. Compr Psychiatry. 2007;48(1):88–94.PubMedCrossRef
20.
Nasrallah H, Morosini P, Gagnon DD. Reliability, validity and ability to detect change of the personal and social performance scale in patients with stable schizophrenia. Psychiatry Res. 2008;161(2):213–24.PubMedCrossRef
21.
Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–76.PubMedCrossRef
22.
Nicotra E, et al. On the use of the positive and negative syndrome scale in randomized clinical trials. Schizophr Res. 2015;165(2–3):181–7.PubMedCrossRef
23.
Ruhe HG, et al. Clinical use of the Hamilton depression rating scale: is increased efficiency possible? A post hoc comparison of Hamilton depression rating scale, Maier and Bech subscales, clinical global impression, and symptom Checklist-90 scores. Compr Psychiatry. 2005;46(6):417–27.PubMedCrossRef
24.
Young RC, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429–35.PubMedCrossRef
25.
Lukasiewicz M, et al. Young mania rating scale: how to interpret the numbers? Determination of a severity threshold and of the minimal clinically significant difference in the EMBLEM cohort. Int J Methods Psychiatr Res. 2013;22(1):46–58.PubMedCrossRef
26.
McGuire AB, et al. Rasch analysis of the illness management and recovery scale-clinician version. J Eval Clin Pract. 2014;20(4):383–9.PubMedCrossRef
27.
Armstrong NP, et al. Validating a brief version of the mental health recovery measure for individuals with schizophrenia. Psychiatr Serv. 2014;65(9):1154–9.PubMedCrossRef
28.
Snyder CR, et al. The will and the ways: development and validation of an individual-differences measure of hope. J Pers Soc Psychol. 1991;60(4):570–85.PubMedCrossRef
29.
Larsen DL, et al. Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann. 1979;2(3):197–207.PubMedCrossRef
30.
Søgaard HJ, et al. Psykiatrisk patientsregistrering Det psykiatriske centralregister i Danmark. En analyse af kritikken for og imod. Nordisk Psykiatrisk Tidsskrift. 1991;45(5):323–8.CrossRef
31.
32.
Dalum HS, et al. Participants' and staffs' evaluation of the illness management and recovery program: a randomized clinical trial. J Ment Health. 2016:1–8.
33.
34.
Roosenschoon BJ, et al. Illness Management & Recovery (IMR) in the Netherlands; a naturalistic pilot study to explore the feasibility of a randomized controlled trial. BMC Psychiatry. 2016;16(1):391.PubMedPubMedCentralCrossRef
35.
Zhao, S., et al., Psychoeducation (brief) for people with serious mental illness. Cochrane Database Syst Rev, 2015(4): p. CD010823.
36.
Mueser KT, et al. Illness management and recovery: a review of the research. Psychiatr Serv. 2002;53(10):1272–84.PubMedCrossRef
37.
Higgens, J.G.S.e., The Cochrane Collaboration. Vol. version 5.1.0 [updated March 2011]. 2011: Cochrane handbook for systematic reviews of interventions.
38.
Lundh A, Sismondo S, Lexchin J, et al. Industry sponsorship and research outcome. Cochrane Database Syst Rev. 2012;12:MR000033.PubMed
39.
Savovic J, et al. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies. Health Technol Assess. 2012;16(35):1–82.PubMedCrossRef
40.
Wood L, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ. 2008;336(7644):601–5.PubMedPubMedCentralCrossRef
41.
Roosenschoon BJ, et al. Effectiveness of illness management and recovery (IMR) in the Netherlands: a randomised clinical trial. BMC Psychiatry. 2016;16:73.PubMedPubMedCentralCrossRef
Metadata
Title
Illness management and recovery: one-year follow-up of a randomized controlled trial in Danish community mental health centers: long-term effects on clinical and personal recovery
Authors
Sofie Bratberg Jensen
Helle Stentoft Dalum
Lisa Korsbek
Carsten Hjorthøj
John Hagel Mikkelsen
Karin Thomsen
Kristen Kistrup
Mette Olander
Jane Lindschou
Kim T. Mueser
Merete Nordentoft
Lene Falgaard Eplov
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2019
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-019-2048-0

Other articles of this Issue 1/2019

BMC Psychiatry 1/2019 Go to the issue

Research article

Systematic review and meta-analysis of the relationship between sleep disorders and suicidal behaviour in patients with depression

Research article

Postpartum psychosis in bipolar disorder: no evidence of association with personality traits, cognitive style or affective temperaments

Research article

Motivations and experiences of volunteers and patients in mental health befriending: a thematic analysis

Research article

Moral cognition, the missing link between psychotic symptoms and acts of violence: a cross-sectional national forensic cohort study

Research article

Psychological interventions for managing postpartum psychosis: a qualitative analysis of women’s and family members’ experiences and preferences

Correction

Correction to: After the Fort McMurray wildfire there are significant increases in mental health symptoms in grade 7–12 students compared to controls